Association between Type 2 Diabetes Mellitus and Brain Atrophy: A Meta-Analysis
- PMID: 35255549
- PMCID: PMC9532183
- DOI: 10.4093/dmj.2021.0189
Association between Type 2 Diabetes Mellitus and Brain Atrophy: A Meta-Analysis
Abstract
Background: Type 2 diabetes mellitus (T2DM) is known to be associated with cognitive decline and brain structural changes. This study systematically reviews and estimates human brain volumetric differences and atrophy associated with T2DM.
Methods: PubMed, PsycInfo and Cochrane Library were searched for brain imaging studies reporting on brain volume differences between individuals with T2DM and healthy controls. Data were examined using meta-analysis, and association between age, sex, diabetes characteristics and brain volumes were tested using meta-regression.
Results: A total of 14,605 entries were identified; after title, abstract and full-text screening applying inclusion and exclusion criteria, 64 studies were included and 42 studies with compatible data contributed to the meta-analysis (n=31,630; mean age 71.0 years; 44.4% male; 26,942 control; 4,688 diabetes). Individuals with T2DM had significantly smaller total brain volume, total grey matter volume, total white matter volume and hippocampal volume (approximately 1% to 4%); meta-analyses of smaller samples focusing on other brain regions and brain atrophy rate in longitudinal investigations also indicated smaller brain volumes and greater brain atrophy associated with T2DM. Meta-regression suggests that diabetes-related brain volume differences start occurring in early adulthood, decreases with age and increases with diabetes duration.
Conclusion: T2DM is associated with smaller total and regional brain volume and greater atrophy over time. These effects are substantial and highlight an urgent need to develop interventions to reduce the risk of T2DM for brain health.
Keywords: Atrophy; Brain; Diabetes mellitus, type 2; Neuroimaging.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
Comment in
-
Association between Type 2 Diabetes Mellitus and Brain Atrophy: A Meta-Analysis (Diabetes Metab J 2022;46:781-802).Diabetes Metab J. 2022 Sep;46(5):813-814. doi: 10.4093/dmj.2022.0259. Epub 2022 Sep 19. Diabetes Metab J. 2022. PMID: 36193729 Free PMC article. No abstract available.
-
Association between Type 2 Diabetes Mellitus and Brain Atrophy: A Meta-Analysis (Diabetes Metab J 2022;46:781-802).Diabetes Metab J. 2022 Sep;46(5):815-816. doi: 10.4093/dmj.2022.0296. Epub 2022 Sep 19. Diabetes Metab J. 2022. PMID: 36193730 Free PMC article. No abstract available.
Similar articles
-
Type 2 diabetes mellitus accelerates brain aging and cognitive decline: Complementary findings from UK Biobank and meta-analyses.Elife. 2022 May 24;11:e73138. doi: 10.7554/eLife.73138. Elife. 2022. PMID: 35608247 Free PMC article.
-
The adverse impact of type 2 diabetes on brain volume in heart failure.J Clin Exp Neuropsychol. 2013;35(3):309-18. doi: 10.1080/13803395.2013.771617. Epub 2013 Feb 18. J Clin Exp Neuropsychol. 2013. PMID: 23419083 Free PMC article.
-
Meta-analyses of structural regional cerebral effects in type 1 and type 2 diabetes.Brain Imaging Behav. 2015 Dec;9(4):651-62. doi: 10.1007/s11682-014-9348-2. Brain Imaging Behav. 2015. PMID: 25563229
-
A systematic review and meta-analysis of longitudinal hippocampal atrophy in healthy human ageing.Neuroimage. 2015 May 15;112:364-374. doi: 10.1016/j.neuroimage.2015.03.035. Epub 2015 Mar 20. Neuroimage. 2015. PMID: 25800208 Review.
-
Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep. Report No.: 18-05239-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep. Report No.: 18-05239-EF-1. PMID: 30354042 Free Books & Documents. Review.
Cited by
-
Diabetes: a tipping point in neurodegenerative diseases.Trends Mol Med. 2023 Dec;29(12):1029-1044. doi: 10.1016/j.molmed.2023.09.005. Epub 2023 Oct 10. Trends Mol Med. 2023. PMID: 37827904 Free PMC article. Review.
-
Cognitive dysfunction in diabetes: abnormal glucose metabolic regulation in the brain.Front Endocrinol (Lausanne). 2023 Jun 16;14:1192602. doi: 10.3389/fendo.2023.1192602. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37396164 Free PMC article. Review.
-
Current Insights on the Use of Insulin and the Potential Use of Insulin Mimetics in Targeting Insulin Signalling in Alzheimer's Disease.Int J Mol Sci. 2022 Dec 13;23(24):15811. doi: 10.3390/ijms232415811. Int J Mol Sci. 2022. PMID: 36555450 Free PMC article. Review.
-
Accelerometer-Measured Behavior Patterns in Incident Cerebrovascular Disease: Insights for Preventative Monitoring From the UK Biobank.J Am Heart Assoc. 2024 Jun 4;13(11):e032965. doi: 10.1161/JAHA.123.032965. Epub 2024 May 31. J Am Heart Assoc. 2024. PMID: 38818948 Free PMC article.
-
Hyperglycemia selectively increases cerebral non-oxidative glucose consumption without affecting blood flow.bioRxiv [Preprint]. 2024 Sep 10:2024.09.05.611035. doi: 10.1101/2024.09.05.611035. bioRxiv. 2024. PMID: 39314314 Free PMC article. Preprint.
References
-
- Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93:137–88. - PubMed
-
- Cheng G, Huang C, Deng H, Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J. 2012;42:484–91. - PubMed
-
- Cherbuin N, Walsh EI. Sugar in mind: untangling a sweet and sour relationship beyond type 2 diabetes. Front Neuroendocrinol. 2019;54:100769. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical